You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

well-differentiated thyroid cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

Recruiting
  • Thyroid Cancer
  • +2 more
    • Taipei, Taiwan
      Chih-Yuan Wang, M.D
    Oct 16, 2022

    Recurrence in Patients With Differentiated Thyroid Cancer

    Not yet recruiting
    • Differentiated Thyroid Cancer
    • (no location specified)
    Nov 30, 2023

    Thyroid Trial in Philadelphia (Metformin Hydrochloride, Radioactive Iodine, Placebo)

    Active, not recruiting
    • Thyroid
    • Metformin Hydrochloride
    • +2 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Aug 31, 2021

    Thyroid Neoplasia, Well-Differentiated Thyroid Cancer, Medullary Thyroid Cancer Trial in São Paulo (Laser ablation,

    Recruiting
    • Thyroid Neoplasia
    • +3 more
    • Laser ablation
    • +2 more
    • São Paulo, Brazil
      Instituto do Cancer do Estado de São Paulo
    Feb 23, 2021

    Differentiated Thyroid Cancer Patients Treated With Different

    Not yet recruiting
    • Thyroid Cancer
    • (no location specified)
    Nov 15, 2023

    Postoperative Re-stratification for Recurrence in

    Completed
    • Well Differentiated Thyroid Carcinoma
    • Papillary Thyroid Cancer
    • UNILATERAL THYROIDECTOMY
    • (no location specified)
    Aug 4, 2020

    Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)

    Recruiting
    • Thyroid Cancer
    • Traditional neck dissection approach
    • Anterior neck dissection approach
    • Medellin, Antioquia, Colombia
      Hospital Alma Mater de Antioquia
    Nov 20, 2023

    Efficacy of Lenvatinib in Differentiated Thyroid Cancer

    Recruiting
    • Differentiated Thyroid Cancer
    • Gender
    • Rome, Italy
      Regina Elena National Cancer Institute
    Mar 16, 2023

    Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

    Active, not recruiting
    • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
    • +25 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Torrance, California
    • +6 more
    Jan 12, 2023

    18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

    Recruiting
    • Differentiated Thyroid Gland Carcinoma
    • +2 more
    • Computed Tomography
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

    Recruiting
    • Differentiated Thyroid Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 9, 2023

    Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)

    Not yet recruiting
    • Differentiated Thyroid Cancer
    • +3 more
    • Larotrectinib monotherapy
    • 131I therapy
    • (no location specified)
    Mar 13, 2023

    Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

    Not yet recruiting
    • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
    • Anlotinib Hydrochloride Capsule and Penpulimab
    • Beijing, Beijing, China
      YansongLin
    Sep 25, 2023

    Quality of Life in Differentiated Thyroid Carcinoma Undergoing

    Not yet recruiting
    • Thyroid Cancer
    • minimally invasive procedure
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hopsital
    Sep 13, 2023

    Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

    Not yet recruiting
    • Differentiated Thyroid Cancer
    • Pavia, Lombardia, Italy
      Istituti Clinici Scientifici Maugeri
    May 5, 2023

    Differentiated Thyroid Cancer Trial in China (AL2846 capsule)

    Recruiting
    • Differentiated Thyroid Cancer
    • AL2846 capsule
    • Guilin, Guangxi, China
    • +3 more
    Feb 27, 2023

    Thyroglobulin Point of Care Assay for Rapid Detection of

    Recruiting
    • Differentiated Thyroid Cancer
    • Lymph Node Metastases
    • Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
    • Ashkelon, Israel
    • +2 more
    Oct 25, 2022

    Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,

    Recruiting
    • Thyroid Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Locally Advanced or Metastatic Radioiodine-Refractory

    Recruiting
    • Thyroid Neoplasms
    • Anlotinib Hydrochloride Capsule
    • Beijing, Beijing, China
    • +2 more
    Aug 9, 2023

    Differentiated Thyroid Cancer Trial in Beijing (Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH), radioactive

    Recruiting
    • Differentiated Thyroid Cancer
    • Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH)
    • radioactive iodine
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Nov 28, 2022

    Renal Tracer Elimination in Thyroid Cancer Patients Treated With

    Completed
    • Thyroid Carcinoma
      • Jena, Thüringen, Germany
        University Hospital Jena
      Dec 15, 2022

      Differentiated Thyroid Cancer Trial (Low iodine diet)

      Not yet recruiting
      • Differentiated Thyroid Cancer
      • Low iodine diet
      • (no location specified)
      Oct 25, 2022

      Differentiated Thyroid Cancer Trial in Spain (Cabozantinib)

      Not yet recruiting
      • Differentiated Thyroid Cancer
      • Oviedo, Asturias, Spain
      • +9 more
      Dec 14, 2022

      Reminder System (TCARS) Study - A Pilot Study.

      Not yet recruiting
      • Low Risk Differentiated Thyroid Cancer
      • Shared-care model
      • (no location specified)
      Aug 18, 2022

      Thyroid Tumor Follicular, Bone Metastases Trial in Beijing (Sr-89)

      Not yet recruiting
      • Thyroid Neoplasm Follicular
      • Bone Metastases
      • Beijing, China
        Peking Union Medical College Hospital
      Jul 18, 2022